Filtern
Dokumenttyp
Sprache
- Englisch (4)
Referierte Publikation
- ja (4)
Schlagworte
- SWIR (2)
- Antibody conjuagtes (1)
- Application (1)
- Bioimaging (1)
- Calibrated fluorescence measurements (1)
- Charge transfer (1)
- Contrast agent (1)
- Enhancement strategy (1)
- Fluorescent dye (1)
- Gold (1)
- Gold nanocluster (1)
- Gold nanoclusters (1)
- Imaging (1)
- In vivo imaging (1)
- Lifetime (1)
- Ligand (1)
- Mechanism (1)
- Metal cluster (1)
- NIR (1)
- NIR-II (1)
- NIR-II fluorescence (1)
- Nano (1)
- Nanomaterial (1)
- Nanomaterial design (1)
- Ovarian cancer (1)
- Photoluminescence (1)
- Photophysics (1)
- Quantum yield (1)
- SWIR photoluminescence (1)
- Self-assembly (1)
- Sensor (1)
Organisationseinheit der BAM
High photoluminescence of shortwave infrared-emitting anisotropic surface charged gold nanoclusters
(2019)
Incorporating anisotropic surface charges on atomically precise gold nanoclusters (Au NCs) led to a strong absorption in the nearinfrared region and could enable the formation of self-assembled Au NCs xhibiting an intense absorption band at ∼1000 nm. This surface modification showed a striking enhancement of the photoluminescence in the Shortwave Infrared (SWIR) region with a quantum yield as high as 6.1% in water.
Gold-based nanoparticles below 2 nm in size are promising as luminescent probes for in vivo bioimaging, owing to their brightness and rapid renal clearance. However, their use as contrast agents in the near-infrared II (NIR-II, 1000–1700 nm) range remains challenging due to their low photoluminescence (PL) quantum yield. To address this, PL enhancement can be achieved by either rigidifying the ligand-shell structure or increasing the size of the ligand shell. In this study, we synthesized ultra-small gold nanoparticles stabilized by co-ligands, namely monothiol and short dithiol molecules. By precisely controlling the amount of reducing agent used during particle preparation, we successfully modulated the physicochemical properties of the co-ligand shell, including its size, composition, and structure. Consequently, we achieved a remarkable 60-fold increase in the absorption cross-section at 990 nm while maintaining the small size of the 1.5-nm metal core. The analytical and optical characterization of our thiol-capped gold nanoparticles indicates that the ligand shell size is governed by the quantity of the reducing agent, which, in turn, impacts the balance between radiative and non-radiative processes, thereby influencing the PL quantum yield.
The influence of solvent polarity and surface ligand rigidification on the SWIR emission profile of gold nanoclusters with an anistropic surface was investigated. A strong enhancement of the SWIR emission band at 1200 nm was observed when measuring in different local environments: in solution, in polymer composites, and in solids. SWIR in vivo imaging of mice assisted by deep learning after intravenous administration of these gold nanoclusters provides high definition pseudo-3D views of vascular blood vessels.
Using fluorescence-guided surgery (FGS) to cytoreductive surgery helps achieving complete resection of microscopic ovarian tumors. The use of visible and NIR-I fluorophores has led to beneficial results in clinical trials; however, involving NIR-II dyes seems to outperform those benefits due to the deeper tissue imaging and higher signal/noise ratio attained within the NIR-II optical window. In this context, we developed NIR-II emitting dyes targeting human epidermal growth factor receptor 2 (HER2)-positive ovarian tumors by coupling water-soluble NIR-II aza-BODIPY dyes to the FDA-approved anti-HER2 antibody, namely, trastuzumab. These bioconjugated NIR-II-emitting dyes displayed a prolonged stability in serum and a maintained affinity toward HER2 in vitro. We obtained selective targeting of HER2 positive tumors (SKOV-3) in vivo, with a favorable tumor accumulation. We demonstrated the fluorescence properties and the specific HER2 binding of the bioconjugated dyes in vivo and thus their potential for NIR-II FGS in the cancer setting.